Progyny Inc (PGNY)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Cash and cash equivalents US$ in thousands 97,296 158,075 170,570 155,320 120,078 72,520 54,730 38,821 91,413 92,224 48,747 29,820 70,305 53,965 49,392 91,634 80,382 7,664
Short-term investments US$ in thousands 273,791 177,477 111,925 52,569 69,222 68,473 67,655 66,855 28,005 22,086 45,221 77,095 38,994 50,995 41,984
Total current liabilities US$ in thousands 185,950 193,419 193,900 206,867 159,536 156,868 144,897 128,717 98,824 104,484 98,785 100,998 77,786 74,166 57,668 59,056 36,163 57,564
Cash ratio 2.00 1.73 1.46 1.00 1.19 0.90 0.84 0.82 1.21 1.09 0.95 1.06 1.41 1.42 1.58 1.55 2.22 0.13

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($97,296K + $273,791K) ÷ $185,950K
= 2.00

The cash ratio of Progyny Inc has exhibited a generally increasing trend over the past eight quarters, starting at 0.86 in Q1 2022 and rising to 2.14 in Q4 2023. This ratio indicates the company's ability to cover its short-term liabilities with its available cash and cash equivalents.

A cash ratio above 1.0 is typically considered favorable as it suggests that the company has enough cash on hand to meet its short-term obligations. Progyny Inc's consistent improvement in its cash ratio reflects a strengthening liquidity position and a healthier financial position overall.

The significant increase in the cash ratio from 1.03 in Q1 2023 to 2.14 in Q4 2023 indicates a substantial enhancement in the company's ability to cover its short-term liabilities solely with its cash reserves. This trend suggests that Progyny Inc has been effectively managing its cash flows and maintaining adequate liquidity levels to meet its financial obligations.

Overall, the rising trend in the cash ratio of Progyny Inc signals improved financial stability and liquidity, providing a favorable indication of the company's ability to weather potential financial challenges and take advantage of growth opportunities in the future.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash ratio
Progyny Inc
PGNY
2.00
DaVita HealthCare Partners Inc
DVA
0.17
Sotera Health Co
SHC
1.29